This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the design and synthesis of small molecule inhibitors. It is often investigated for its potential to modulate specific biological targets, such as enzymes or receptors, due to its structural complexity and ability to interact with protein binding sites. Researchers explore its application in treating diseases like cancer, inflammation, or neurological disorders by targeting pathways involved in these conditions. Its unique structure, combining a tryptophan moiety with a biphenyl group, allows for selective binding and inhibition, making it a valuable candidate for preclinical studies. Additionally, it serves as a key intermediate in the synthesis of more complex pharmaceutical agents, contributing to the development of novel therapeutics.